Platelet secretory products may contribute to neuronal injury

Stroke

Volumn 22, Issue 11, 1991, Pages 1448-1451

  Joseph, Rajiv ^a   Tsering, Mphil Chock ^a   Grunfeld, S ^a   Welch, K ^a  

^a HENRY FORD HOSPITAL   (United States)

Author keywords

Blood platelets; Neuronal damage

Indexed keywords

HUMAN; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; REVIEW; THROMBOCYTE; THROMBOSIS;

ANIMAL; BLOOD PLATELETS; BRAIN ISCHEMIA; CEREBROVASCULAR DISORDERS; GLIOSIS; GLUTAMATES; GLUTAMIC ACID; HUMAN; NERVOUS SYSTEM DISEASES; NEURONS; PLATELET AGGREGATION; PURPURA, THROMBOTIC THROMBOCYTOPENIC; SEROTONIN;

EID: 0025747980     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/01.STR.22.11.1448     Document Type: Article

References (63)

1. Wintrobe MM: Platelets and megakaryocytes, in Wintrobe MM (ed): Clinical Hematotogy, ed 8. Philadelphia, Pa, Lea & Febiger, 1981, pp 355-379
2. Millikan CH, McDowell FH: Treatment of progressing stroke. Stroke 1981;12:397-409
3. Holmsen H: Platelet secretion, in Colman RW, Hirsh J, Marder VJ, Salzman EW (eds): Thrombosis and Hemostasis, ed 2. Philadelphia, Pa, JB Lippincott Co, 1987, pp 606-617
4. White JW: Anatomy and structural organization of the platelet, in Colman RW, Hirsh J, Marder VJ, Salzman EW (eds): Thrombosis and Hemostasis, ed 2. Philadelphia, Pa, JB Lippincott Co, 1987, pp 537-554
5. Joseph R, Welch KMA, Oster SB, Grunfeld S, D’Andrea G: A plasmatic factor may cause platelet activation in acute ischemic stroke. Circ Res 1989;65:1679-1687
6. Joseph R, D’Andrea G, Oster SB, Welch KMA: Whole blood platelet function in acute ischemic stroke: Importance of dense body secretion and the effects of antithrombotic agents. Stroke 1989;20:38-44
7. Pepper D: Macromolecules released from platelet storage organelles. Thromb Haemost 1979;42:1667-1672
8. Gingrich R, Hoak J: Platelet-endothelial cell interactions. Semin Hematol 1979;16:208-219
9. Clerck F, Van Nueten J: Platelet-mediated vascular contractions. Biochem Pharmacol 1983;32:765-771
10. Fugimoto T, Suzuki H, Tanoue K, Fukushima Y, Yamazaki H: Cerebrovascular injuries induced by activation of platelets in vivo. Stroke 1985; 16:245-250
11. Goldberg ID, Stemerman MB, Handin RI: Vascular permeation of platelet factor 4 after endothelial injury. Science 1980;209:611-612
12. Rapport MM, Green AA, Page IH: Serum vasoconstrictor (serotonin): IV. Isolation and characterization. J Biol Chem 1948;174:1243-1251
13. Joseph R, Welch KMA, D’Andrea G, Riddle JM: Evidence for the presence of red and white cells within “platelet” aggregates formed in whole blood. Thromb Res 1989;53: 485-491
14. Hovig T, Dodds WJ, Rowsell HC, Mustard JF: The transformation of hemostatic platelet plugs in normal and Factor IX deficient dogs. Am J Pathol 1968;53:355-374
15. Leung LLK, Harpel PC, Nachman RL, Rabelino EM: Histi-dine-rich glycoprotein is present in human platelets and is released following thrombin stimulation. Blood 1983;62: 1016-1021
16. Hallenbeck JM, Dutka AJ, Tanishima T, Kochanek PM, Kumaroo KK, Thompson CB, Obrenovitch TP, Contreras TJ: Polymorphonuclear leukocyte accumulation in brain regions with low blood flow during the early postischemic period. Stroke 1986;17:246-253
17. Hervonen H, Steinwall O, Spatz M, Klatzo I: Behaviour of the blood-brain barrier toward biogenic amines in experimental cerebral ischemia. Adv Exp Med Biol 1980;131:295-305
18. Joseph R, Welch KMA, Grunfeld S, Oster SB, D’Andrea G: Baseline and activated platelet cytoplasmic ionized calcium in acute ischemic stroke: Effect of aspirin. Stroke 1988;19: 1234-1238
19. Joseph R, Riddle JM, Welch KMA, D’Andrea G: Platelet ultrastructure and secretion in acute ischemic stroke. Stroke 1989;20:1316-1319
20. Petito CK, Feldmann E, Pulsinelli WA, Plum F: Delayed hippocampal damage in humans following cardiorespiratory arrest. Neurology 1987;37:1281-1286
21. Silverstein A: Thrombotic thrombocytopenic purpura: The initial neurologic manifestations. Arch Neurol 1968; 18: 358-362
22. Actams RD, Cammermeyer J, Fitzgerald PJ: The neuropath-ological aspects of thrombocytic acroangiothrombosis: A clinico-anatomical study of generalized platelet thrombosis. J Neurol Neurosurg Psychiatry 1948;11:27-43
23. Bornstein B, Boss JH, Casper J, Behar M: Thrombotic throm-bocytopenic purpura, report of a case presenting as a chronic neurological disorder and characterized by unusual histo logical findings. J Clin Path 1960;13:124-132
24. Obrenovitch TP, Hallenbeck JM: Platelet accumulation in regions of low blood flow during the postischemic period. Stroke 1985;16:224-234
25. Meyer JS: Localized changes in properties of the blood and effects of anticoagulant drugs in experimental cerebral infarction. N Engl J Med 1958;258:151-159
26. 2 and prostacyclin. Pharmacol Rev 1979;30:293-331
27. Jacobs TP, Shohami E, Baze W, Burgard E, Gunderson C, Hallenbeck JM, Feuerstein G: Deteriorating stroke model: Histopathology, edema, and eicosanoid changes following spinal cord ischemia in rabbits. Stroke 1987; 18:741-750
28. Feuerstein G: Eicosanoids in deteriorating stroke: Review of studies on the rabbit spinal cord ischemia and reperfusion model. Ann N YAcad Sci 1989;559:313-322
29. Gaudet R, Levine L: Transient cerebral ischemia and brain prostaglandins. Biochem Biophys Res Commun 1979;86: 893-901
30. lα in gerbil brain. Stroke 1980;11:648-652
31. Shohami E, Rosenthal J, Lavy S: The effect of incomplete cerebral ischemia on prostaglandin levels in rat brain. Stroke 1982;13:494-498
32. 4 as a possible cause of cerebral edema. Stroke 1988;19:372-377
33. Dempsey RJ, Roy MW, Meyer K, Cowen DE, Tai H-H: Development of cyclooxygenase and lipooxygenase metabolites of arachidonic acid after transient cerebral ischemia. J Neurosurg 1986;64:118-124
34. Harper AM, MacKenzie ET: Cerebral circulatory and metabolic effects of 5-hydroxytryptamine in anaesthetized baboons. J Physiol 1977;271:721-733
35. Welch KMA, Meyer JS, Teraura T, Hashi K, Shinmaru S: Ischemic anoxia and cerebral serotonin levels. J Neurol Sci 1972; 16:85-92
36. Hardisty RM, Stacey RS: 5-Hydroxytryptamine in normal human platelets. J Physiol 1955;130:711-720
37. Bobker DH, Williams JT: Ion conductances affected by 5-HT receptor subtypes in mammalian neurons. TINS 1990;13: 169-173
38. Davies MF, Deisz RA, Prince DA, Peroutka SJ: Two distinct effects of 5-hydroxytryptamine on single cortical neurons. Brain Res 1987;423:347-352
39. Jahnsen H: The action of 5-hydroxytryptamine on neuronal membranes and synaptic transmission in area CA1 of the hippocampus in vitro. Brain Res 1980;1 97:83-94
40. Colino A, Halliwell JV: Differential modulation of three separate K-conduc tances in hippocampal CA1 neurons by serotonin. Nature 1987;328:73-77
41. Rothman SM, Olney JW: Glutamate and the pathophysiology of hypoxic-ischemic brain damage. Ann Neurol 1986;19: 105-111
42. Choi DW, Rothman SM: The role of glutamate neurotoxicity in hypoxic-ischemic neuronal death. Annu Rev Neurosci 1990; 13:171-182
43. Bosley TM, Woodhams PL, Gordon RD, Belazs R: Effects of anoxia on the stimulated release of amino acid neurotransmit-ters in the cerebellum in vitro. J Neurochem 1983;40:189-201
44. Rothman S: Synaptic release of excitatory amino acid neuro-transmitter mediates anoxic neuronal death. J Neurosci 1984; 4:1884-1891
45. Lucas DR, Newhouse JP: The toxic effect of sodium-L-glutamate on the inner layers of retina. Arch Ophthalmol 1957;58:193-201
46. D’Andrea G, Cananzi AR, Ferro-Milone F, Joseph R, Grun-feld S, Welch KMA: Platelet levels of glutamate and aspartate in normal subjects. Stroke 1989;20:299-300
47. Benveniste H, Drejer J, Schousboe A, Diemer NH: Elevation of the extracellular concentrations of glutamate and aspartate in rat hippocampus during transient cerebral ischemia monitored by intracerebral microdialysis. J Neurochem 1984;43: 1369-1374
48. Van Nostrand WE, Schmaier AH, Farrow JS, Cunningham DD: Protease nexin-II (amyloid β-protein precursor): A platelet α-granule protein. Science 1990;248:745-748
49. a-inhibitor, a form of Alzheimer’s amyloid precursor pro-tein. Science 1990;248:l126-1128
50. Cole GM, Galasko D, Shapiro IP, Saitoh T: Stimulated platelets release amyloid J3-protein precursor. Biochem Biophys Res Commun 1990;170:288-295
51. Bush AI, Martins RN, Rumble B, Moir R, Fuller S, Milward E, Currie J, Ames D, Weidemann A, Fischer P, Multhaup G, Beyreuther K, Masters CL: The amyloid precursor protein of Alzheimer’s disease is released by human platelets. J Biol Chem 1990;265:15977-15983
52. Gardella JE, Ghiso J, Gorgone GA, Marratta D, Kaplan AP, Frangione B, Gorevic PD: Intact Alzheimer amyloid precursor protein (APP) is present in platelet membranes and is encoded by platelet mRNA. Biochem Biophys Res Commun 1990;173:1292-1298
53. Yankner BA, Duffy LK, Kirschner DA: Neurotrophic and neurotoxic effects of amyloid β protein: Reversal by tachykinin neuropeptides. Science 1990;250:279-282
54. Yankner BA, Caceres A, Duffy LK: Nerve growth factor potentiates the neurotoxicity of β amyloid. Proc NatlAcad Sci USA 1990;87:9020-9023
55. Ross R, Glomset J, Kariya B, Harker L: A pl atelet-de pendent serum factor that stimulates the proliferation of arterial smooth muscle cells in vitro. Proc Natl Acad Sci USA 1974;71:1207-1210
56. Assoian RK, Grotendorst GR, Miller DM, Sporn MB: Cellular transformation by coordinated action of three peptide growth factors from human platelets. Nature 1984;309: 804-806
57. Assoian RK, Sporn MB: Type β transforming growth factor in human platelets: Release during platelet degranulation and action on vascular smooth muscle cells. J Cell Biol 1986;102: 1217-1223
58. Ross R, Raines EW, Bowen-Pope DF: The biology of platelet-derived growth factor. Cell 1986;46:155-169
59. Westermark B, Wasteson A: A platelet factor stimulating human normal glial cells. Exp Cell Res 1976;98:170-174
60. Besnard F, Perraud F, Sensenbrenner M, Labourdette G: Platelet-derived growth factor is a mitogen for glial but not for neuronal rat brain cells in vitro. Neurosci Lett 1987;73:287-292
61. Joseph R, Saroff DM, Delfs JR: Platelet secretory products have damaging effect on neurons (abstract 330). Proceedings of the American Association for the Advancement of Science, Washington, DC, February 18, 1991
62. Joseph R, Saroff DM, Delfs JR: Platelets and their products have damaging effects on neurons (abstract). Neurology 1991; 41(suppl 1):163
63. Joseph R, Tsering C, Grunfeld S, Welch KMA: Serotonin may mediate platelet neurotoxicity (abstract). J Neurosci 1991;17: 1093